Biotechnology

Lessons learned from COVID-19 vaccines could advance synthetic biology. Here's how

Image: Pexels.

Gillian Marcelle

Managing Member, Resilience Capital Ventures

Keolu Fox

Professor, University of California, San Diego (UCSD)

Santanu Dasgupta

Senior Vice-President, Reliance Industries

Share:

The Big Picture
Explore and monitor how Biotechnology is affecting economies, industries and global issues
Crowdsource Innovation
Get involved with our crowdsourced digital platform to deliver impact at scale

Stay up to date:

Biotechnology

Have you read?

Discover

What is the World Economic Forum doing about the Fourth Industrial Revolution?

License and Republishing

World Economic Forum articles may be republished in accordance with the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International Public License, and in accordance with our Terms of Use.

The views expressed in this article are those of the author alone and not the World Economic Forum.

Related topics:

BiotechnologyScienceFourth Industrial RevolutionEmerging Technologies

Share:

Global Agenda

The Agenda Weekly

A weekly update of the most important issues driving the global agenda

Subscribe

You can unsubscribe at any time using the link in our emails. For more details, review our privacy policy.

Turning cells into better protein factories could help improve gene therapies. Here's how
About Us
Events
Media
Partners & Members
Language Editions

Privacy Policy & Terms of Service

© 2022 World Economic Forum